Latest | F'cast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | -201.4% | n/a |
ROCE | n/a |
Latest | F'cast | |
---|---|---|
P/E | n/a | n/a |
PEG | n/a | n/a |
Pr/Revenue | 15.0 | n/a |
Pr/Book | 9.5 |
Latest | F'cast | |
---|---|---|
Revenue | -60.8% | n/a |
PBT | n/a | n/a |
EPS | n/a | n/a |
DPS | n/a | n/a |
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Mar-20 | 3.90 | (1.07) | (3.20)p | n/a | n/a | n/a | n/a | 0.0% |
31-Mar-21 | 4.16 | (1.26) | (0.12)p | n/a | n/a | n/a | n/a | 0.0% |
31-Mar-22 | 4.80 | (1.33) | (4.60)p | n/a | n/a | n/a | n/a | 0.0% |
31-Mar-23 | 2.90 | (2.86) | (10.00)p | n/a | n/a | n/a | n/a | 0.0% |
31-Mar-24 | 1.14 | (2.29) | (3.90)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Contract Win | 28-Aug-2025 | 07:00 | RNS |
Contract wins with existing client | 27-Aug-2025 | 07:00 | RNS |
Grant of U.S. Patent for OptiMAL | 05-Aug-2025 | 07:00 | RNS |
No deals were found in the last 28 days.
Currency | UK Pounds |
Share Price | 17.00p |
Change Today | 2.00p |
% Change | 13.33 % |
52 Week High | 17.50 |
52 Week Low | 2.95 |
Volume | 743,378 |
Shares Issued | 113.66m |
Market Cap | £19.32m |
Beta | 0.00 |
RiskGrade | 464 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
No dividends found |
Time | Volume / Share Price |
16:10 | 50,000 @ 17.00p |
16:09 | 50,000 @ 17.00p |
15:43 | 45,568 @ 16.45p |
16:28 | 4 @ 17.48p |
16:27 | 8,011 @ 17.40p |
Chair | Simon Gordon Douglas |
CEO | Adrian Kinkaid |
You are here: research